A team of researchers from UCSF and UC San Diego has identified an approved arthritis drug that is effective against amoebas in lab and animal studies, suggesting it could offer a low-dose, low cost treatment for the amoebic infections that cause human dysentery throughout the world.
May 17, 2012
Viral hepatitis chronically infects between 3.5 and 5.2 million people in the U.S. – more than 30,000 in San Francisco, alone – but only about one in three people who are infected know it, according to a report by the U.S. Department of Health and Human Services.
April 24, 2012
To celebrate World Malaria Day 2012, on Wednesday, April 25, the UCSF Global Health Group and local non-profit Zagaya are hosting the Bay Area World Malaria Day Symposium.
February 29, 2012
A drug once taken by people with HIV/AIDS, but long ago shelved after newer, modern antiretroviral therapies became available, has now shed light on how the human body uses its natural immunity to fight the virus — work that could help uncover new targets for drugs.
February 03, 2012
A new analysis published this week demonstrates that confronting several diseases at once is a viable way to make the most of limited donor dollars and national health care budgets, and save more lives.
November 30, 2011
A cheaper laboratory test that helps guide anti-retroviral drug treatment for people with HIV/AIDS may be just as effective as a more sophisticated test, a group of international researchers has found – a discovery that could be particularly important in rural Africa.
November 10, 2011
Microbes that dwell within us can help or harm us, according to UCSF experts at "Gut Check," a lunchtime panel discussion hosted by UCSF as part of the Bay Area Science Festival last week.
October 17, 2011
A new global Atlas charts prospects for malaria elimination by offering the first full-color, detailed depiction of a disease now declining in many parts of the globe and provides a visual tool to help focus resources where they are needed most.
October 10, 2011
Smoking could cause 18 million more cases of tuberculosis worldwide over the next 40 years and 40 million additional deaths.